Spirulina and Necroptosis

The RIPK1-RIPK3-MLKL Axis

Necroptosis is regulated necrotic cell death proceeding through RIPK1-RIPK3 interaction (via RHIM domains), forming the necrosome. RIPK3 phosphorylates MLKL (mixed lineage kinase-like) at Thr357/Ser358, triggering MLKL oligomerization and plasma membrane translocation. MLKL membrane insertion forms pores, causing necrotic membrane rupture. Unlike apoptosis, necroptosis releases damage-associated molecular patterns (DAMPs), driving secondary inflammation.

Caspase-8: The Necroptosis Switch

Caspase-8 cleaves and inactivates RIPK1, normally suppressing necroptosis. When caspase-8 is inhibited (viral infection, drug treatment, pathological conditions), the cell can't complete apoptosis but instead routes to necroptosis. This programmed alternative ensures infected/damaged cells still die. Spirulina's preservation of caspase-8 expression and activity (through reduced oxidative stress) maintains the apoptosis-necroptosis balance.

Necroptosis in Ischemia-Reperfusion

Stroke and myocardial infarction involve ischemia-reperfusion injury where necroptosis drives infarct expansion. RIPK3 inhibitors and MLKL inhibitors reduce infarct size in animal models by 30–50%. Spirulina pre-treatment in cerebral ischemia models reduces RIPK3 phosphorylation by 25–40% and MLKL oligomerization, with corresponding 25–35% infarct volume reduction.

IBD and Intestinal Epithelial Necroptosis

Inflammatory bowel disease involves intestinal epithelial cell necroptosis driven by TNF-α-RIPK1-RIPK3-MLKL. Caspase-8 loss in IBD permits necroptosis instead of controlled apoptosis. Spirulina's effects on inflammation and barrier function (covered elsewhere) include reduced epithelial necroptosis — 20–35% MLKL phosphorylation reduction in DSS colitis models.

Necroinflammation Loop

Necroptotic cells release DAMPs (HMGB1, mtDNA, ATP) that activate innate immune cells, driving inflammation that promotes further necroptosis — the necroinflammation cycle. Phycocyanin breaks this cycle through reduced inflammation, fewer necroptotic events, and reduced DAMP release. Net systemic DAMP burden falls in chronic inflammation interventions.

Conclusion

Spirulina dampens pathological necroptosis through caspase-8 preservation, inflammation reduction lowering RIPK1-RIPK3 necrosome formation, and Nrf2-mediated antioxidant defense reducing MLKL oligomerization. Quantified effects: 25–40% reduction in RIPK3 phosphorylation, 20–35% MLKL inhibition in disease models, and 25–35% infarct reduction in ischemia-reperfusion. The clinical relevance spans stroke recovery, MI protection, IBD, and emerging implications in neurodegeneration where necroptotic neuronal loss has been documented.